Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster of Infanrix+Hib and Poliorix in Chinese Toddlers
NCT01449812Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2011
- Primary completion
- Jan 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of Infanrix Hib and Poliorix in diphtheria, Tetanus, pertussis and 2 more (3 arms), sponsored by GSK. Primary endpoints: Number of Seroprotected Subjects Against Diphtheria (D) and Tetanus (T) Toxoids at Month 1, Anti-D and Anti-T Antibody Concentrations at Month 1 and 7 more. Started Oct 2011; status: completed.
02
Drugs
Infanrix HibPoliorix
03
Conditions
diphtheriaTetanuspertussispoliomyelitisHaemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT01449812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01449812.